HealthEquity’s (HQY) “Hold” Rating Reiterated at Robert W. Baird
HealthEquity, Inc. (NASDAQ:HQY)‘s stock had its “hold” rating reaffirmed by investment analysts at Robert W. Baird in a research report issued on Thursday.
Other equities analysts have also issued reports about the company. Cantor Fitzgerald lifted their price objective on HealthEquity from $50.00 to $55.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 7th. Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $61.00 price target (up from $57.00) on shares of HealthEquity in a research note on Monday, June 12th. BidaskClub lowered HealthEquity from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. Zacks Investment Research raised HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 price target on the stock in a research note on Wednesday, July 12th. Finally, Chardan Capital boosted their price target on HealthEquity from $53.00 to $57.00 and gave the company a “buy” rating in a research note on Wednesday, June 7th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $56.50.
HealthEquity (NASDAQ HQY) traded down 1.46% during mid-day trading on Thursday, reaching $47.95. The company had a trading volume of 513,747 shares. HealthEquity has a one year low of $30.34 and a one year high of $54.95. The firm has a market capitalization of $2.90 billion, a P/E ratio of 71.14 and a beta of 1.75. The firm’s 50-day moving average is $44.62 and its 200-day moving average is $46.01.
HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, topping the Zacks’ consensus estimate of $0.14 by $0.13. The company had revenue of $56.90 million for the quarter, compared to analyst estimates of $55.66 million. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. The firm’s quarterly revenue was up 28.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.16 earnings per share. On average, equities research analysts anticipate that HealthEquity will post $0.71 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This article was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.thecerbatgem.com/2017/09/21/healthequitys-hqy-hold-rating-reiterated-at-robert-w-baird.html.
In other news, major shareholder Berkley Capital, Llc sold 54,967 shares of the business’s stock in a transaction that occurred on Friday, June 23rd. The stock was sold at an average price of $51.78, for a total transaction of $2,846,191.26. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Frank Medici sold 23,649 shares of the business’s stock in a transaction that occurred on Wednesday, July 5th. The shares were sold at an average price of $50.27, for a total value of $1,188,835.23. Following the sale, the director now owns 6,381 shares of the company’s stock, valued at approximately $320,772.87. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,676,034 shares of company stock worth $85,025,200. Insiders own 29.00% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Wasatch Advisors Inc. increased its holdings in shares of HealthEquity by 2.2% during the second quarter. Wasatch Advisors Inc. now owns 2,442,180 shares of the company’s stock valued at $121,694,000 after acquiring an additional 52,885 shares in the last quarter. Public Employees Retirement System of Ohio increased its holdings in shares of HealthEquity by 5.7% during the second quarter. Public Employees Retirement System of Ohio now owns 113,534 shares of the company’s stock valued at $5,657,000 after acquiring an additional 6,095 shares in the last quarter. Amussen Hunsaker & Associates LLC bought a new stake in shares of HealthEquity during the second quarter valued at approximately $11,598,000. 1st Global Advisors Inc. bought a new stake in shares of HealthEquity during the second quarter valued at approximately $213,000. Finally, Piedmont Investment Advisors LLC bought a new stake in shares of HealthEquity during the second quarter valued at approximately $478,000. Hedge funds and other institutional investors own 90.97% of the company’s stock.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Stock Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related stocks with our FREE daily email newsletter.